Scientific program leader
prof. dr. E. Hak is a SMBWO-acknowledged Senior Epidemiologist since 2001 and full professor of clinical pharmacoepidemiology at the Groningen Research Institute of Pharmacy since 2010.
Expertise at the University Groningen
Courses will be given by the unit PharmacoTherapy, -Epidemiology & -Economics (PTE2) which is part of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCEPP, see www.encepp.eu) and part of the SHARE graduate school. Elective courses and master projects can be followed at the units of PTE2 of the Pharmacy department as well as the Epidemiology and Clinical Pharmacy and Pharmacology departments of the University Medical Center Groningen. At these units, years of experience is available through research in the specific field of clinical epidemiology and pharmacoepidemiology.
Areas of expertise of the participating units:
- Drug utilization and adherence (prof. dr. P. Denig, prof. dr. K. Taxis, prof. dr. E. Hak, dr. J. van Boven, Dr. Schuiling-Veninga);
- Epidemiology of vaccine-preventable diseases (prof. dr. E. Hak);
- Prognostic and diagnostic (oncological) epidemiological studies (prof. dr. E. Hak. prof. dr. G. de Bock);
- Genetic pharmacoepidemiology (prof. dr. B. Wilffert);
- Pharmacovigilance (prof. dr. K. Taxis. prof. dr. E. van Puijenbroek);
- Statistical modeling, meta-analyses and mixed treatment comparisons (prof. dr. E. Hak);
- Observational intervention studies (prof. dr. E. Hak, prof. dr. K. Taxis, Dr. Schuiling-Veninga);
- Clinical trial methodology (prof. dr. E. Hak, prof. dr. B. Wilffert);
- Pregnancy studies Dr. Schuiling-Veninga, prof. dr. E. Hak, prof. dr. B. Wilffert);
- Evidence based medicine/pharmacology (all).
Recognizability of track and distinguishing features from other Epidemiology MScs
The Pharmacoepidemiology track focuses its contents on pharmaceutical research, notably pharmacovigilance, database research, observational and trial intervention methodology and utilization studies with specific attention to the role of pharmaceuticals in healthy ageing. This focus on pharmaceuticals is not part of other Epidemiology MScs such as the Top-master Clinical and Psychosocial Epidemiology of the UMCG or other Epidemiology master courses.